Abstract
Aim:
Baroreflex dysfunction is associated with a higher rate of sudden death after myocardial infarction (MI). Ketanserin enhances baroreflex function in rats. The present work was designed to examine whether ketanserin improves the post-MI cardiac function and to explore the possible mechanism involved.
Methods:
Spontaneously hypertensive rats (SHR) were treated with ketanserin (0.3 mg·kg−1·d−1). Two weeks later, blood pressure and baroreflex function were measured, followed by a ligation of the left coronary artery. The expressions of vesicular acetylcholine transporter (VAChT) and α7 nicotinic acetylcholine receptor (α7-nAChR) in ischemic myocardium, angiogenesis, cardiac function, and left ventricular (LV) remodeling were evaluated subsequently.
Results:
Ketanserin significantly improved baroreflex sensitivity (0.62±0.21 vs 0.34±0.12 ms/mmHg, P<0.01) and vagal tonic activity (heart rate changes in response to atropine, 54.8±16.2 vs 37.6±13.4 bpm, P<0.01) without affecting the blood pressure or basic heart rate in SHR. Treatment of SHR with ketanserin prominently improved cardiac function and alleviated LV remodeling, as reflected by increases in the ejection fraction, fractional shortening, and LV systolic pressure as well as decreases in LV internal diameter and LV relative weight. The capillary density, vascular endothelial growth factor expression, and blood flow in the ischemic myocardium were significantly higher in the ketanserin-treated group. In addition, ketanserin markedly increased the expression of VAChT and α7-nAChR in ischemic myocardium.
Conclusion:
Ketanserin improved post-MI cardiac function and angiogenesis in ischemic myocardium. The findings provide a mechanistic basis for restoring baroreflex function using ketanserin in the treatment of MI.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Executive summary: heart disease and stroke statistics — 2012 update: a report from the American Heart Association. Circulation 2012; 125: 188–97.
Norris RM, Barnaby PF, Brandt PW, Geary GG, Whitlock RM, Wild CJ, et al. Prognosis after recovery from first acute myocardial infarction: determinants of reinfarction and sudden death. Am J Cardiol 1984; 53: 408–13.
Califf RM, Phillips HR 3rd, Hindman MC, Mark DB, Lee KL, Behar VS, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol 1985; 5: 1055–63.
Bigger JT Jr, Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM . The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984; 69: 250–8.
Billman GE, Schwartz PJ, Stone HL . Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 1982; 66: 874–80.
Schwartz PJ, Vanoli E, Stramba-Badiale M, De Ferrari GM, Billman GE, Foreman RD . Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. Circulation 1988; 78: 969–79.
La Rovere MT, Specchia G, Mortara A, Schwartz PJ . Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. Circulation 1988; 78: 816–24.
La Rovere MT, Bigger JT Jr, Marcus FI, Mortara A, Schwartz PJ . Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351: 478–84.
De Ferrari GM, Sanzo A, Bertoletti A, Specchia G, Vanoli E, Schwartz PJ . Baroreflex sensitivity predicts long-term cardiovascular mortality after myocardial infarction even in patients with preserved left ventricular function. J Am Coll Cardiol 2007; 50: 2285–90.
La Rovere MT, Bersano C, Gnemmi M, Specchia G, Schwartz PJ . Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation 2002; 106: 945–9.
Jorge L, Rodrigues B, Rosa KT, Malfitano C, Loureiro TC, Medeiros A, et al. Cardiac and peripheral adjustments induced by early exercise training intervention were associated with autonomic improvement in infarcted rats: role in functional capacity and mortality. Eur Heart J 2011; 32: 904–12.
Fu YJ, Shu H, Miao CY, Wang MW, Su DF . Restoration of baroreflex function by ketanserin is not blood pressure dependent in conscious freely moving rats. J Hypertens 2004; 22: 1165–72.
Xie HH, Shen FM, Cao YB, Li HL, Su DF . Effects of low-dose ketanserin on blood pressure variability, baroreflex sensitivity and end–organ damage in spontaneously hypertensive rats. Clin Sci (Lond) 2005; 108: 547–52.
Miao CY, Xie HH, Yu H, Chu ZX, Su DF . Ketanserin stabilizes blood pressure in conscious spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2003; 30: 189–93.
Shen FM, Wang J, Ni CR, Yu JG, Wang WZ, Su DF . Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT2A receptors. Clin Exp Pharmacol Physiol 2007; 34: 702–7.
Landmesser U, Wollert KC, Drexler H . Potential novel pharmacological therapies for myocardial remodelling. Cardiovasc Res 2009; 81: 519–27.
Tongers J, Losordo DW, Landmesser U . Stem and progenitor cell–based therapy in ischaemic heart disease: promise, uncertainties, and challenges. Eur Heart J 2011; 32: 1197–206.
Yu JG, Song SW, Shu H, Fan SJ, Liu AJ, Liu C, et al. Baroreflex deficiency hampers angiogenesis after myocardial infarction via acetylcholine-α7-nicotinic ACh receptor in rats. Eur Heart J 2013; 34: 2412–20.
Yu JG, Wu J, Shen FM, Cai GJ, Liu JG, Su DF . Arterial baroreflex dysfunction fails to mimic Parkinson's disease in rats. J Pharmacol Sci 2008; 108: 56–62.
Liu AJ, Zang P, Guo JM, Wang W, Dong WZ, Guo W, et al. Involvement of acetylcholine-alpha7nAChR in the protective effects of arterial baroreflex against ischemic stroke. CNS Neurosci Ther 2012; 18: 918–26.
Yang YL, Yu LT, Wu ZT, Yu JG, Zhang JM, Chen QH, et al. Synergic effects of levamlodipine and bisoprolol on blood pressure reduction and organ protection in spontaneously hypertensive rats. CNS Neurosci Ther 2012; 18: 471–4.
Kumarswamy R, Lyon AR, Volkmann I, Mills AM, Bretthauer J, Pahuja A, et al. SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway. Eur Heart J 2012; 33: 1067–75.
Gaemperli O, Shalhoub J, Owen DR, Lamare F, Johansson S, Fouladi N, et al. Imaging intraplaque inflammation in carotid atherosclerosis with 11C-PK11195 positron emission tomography/computed tomography. Eur Heart J 2012; 33: 1902–10.
Quarta G, Syrris P, Ashworth M, Jenkins S, Zuborne Alapi K, Morgan J, et al. Mutations in the Lamin A/C gene mimic arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2012; 33: 1128–36.
Ma J, Xiong JY, Hou WW, Yan HJ, Sun Y, Huang SW, et al. Protective effect of carnosine on subcortical ischemic vascular dementia in mice. CNS Neurosci Ther 2012; 18: 745–53.
Cheong SJ, Lee CM, Kim EM, Uhm TB, Jeong HJ, Kim DW, et al. Evaluation of the therapeutic efficacy of a VEGFR2-blocking antibody using sodium-iodide symporter molecular imaging in a tumor xenograft model. Nucl Med Biol 2011; 38: 93–101.
Faintuch BL, Teodoro R, Oliveira EA, Nunez EG, Faintuch J . Neovascularization after ischemic injury: evaluation with 99mTc-HYNIC-RGD. Acta Cir Bras 2011; 26: 58–63.
Selejan S, Poss J, Walter F, Hohl M, Kaiser R, Kazakov A, et al. Ischaemia-induced up-regulation of Toll-like receptor 2 in circulating monocytes in cardiogenic shock. Eur Heart J 2012; 33: 1085–94.
Zou YX, Zhang XH, Su FY, Liu X . Importance of riboflavin kinase in the pathogenesis of stroke. CNS Neurosci Ther 2012; 18: 834–40.
Ma XJ, Cheng JW, Zhang J, Liu AJ, Liu W, Guo W, et al. E-selectin deficiency attenuates brain ischemia in mice. CNS Neurosci Ther 2012; 18: 903–8.
Szardien S, Nef HM, Voss S, Troidl C, Liebetrau C, Hoffmann J, et al. Regression of cardiac hypertrophy by granulocyte colony-stimulating factor-stimulated interleukin-1beta synthesis. Eur Heart J 2012; 33: 595–605.
Liao Y, Bin J, Asakura M, Xuan W, Chen B, Huang Q, et al. Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice. Eur Heart J 2012; 33: 3124–33.
Lo M, Su DF, Julien C, Cerutti C, Vincent M, Sassard J . Influence of hypertension and age on the sympathetic and parasympathetic components of cardiac baroreflex in the conscious rat. Arch Mal Coeur Vaiss 1988; 81 Spec No: 113–7.
Billman GE, Hoskins RS . Time-series analysis of heart rate variability during submaximal exercise. Evidence for reduced cardiac vagal tone in animals susceptible to ventricular fibrillation. Circulation 1989; 80: 146–57.
Li DJ, Evans RG, Yang ZW, Song SW, Wang P, Ma XJ, et al. Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension. Hypertension 2011; 57: 298–307.
Fletcher PJ, Pfeffer JM, Pfeffer MA, Braunwald E . Effects of hypertension on cardiac performance in rats with myocardial infarction. Am J Cardiol 1982; 50: 488–96.
Chen H, Chen SC, Zhang TH, Tian HC, Guan Y, Su DF . Protective effects of silybin and tetrandrine on the outcome of spontaneously hypertensive rats subjected to acute coronary artery occlusion. Int J Cardiol 1993; 41: 103–8.
Emanueli C, Salis MB, Stacca T, Gaspa L, Chao J, Chao L, et al. Rescue of impaired angiogenesis in spontaneously hypertensive rats by intramuscular human tissue kallikrein gene transfer. Hypertension 2001; 38: 136–41.
Takeshita S, Tomiyama H, Yokoyama N, Kawamura Y, Furukawa T, Ishigai Y, et al. Angiotensin-converting enzyme inhibition improves defective angiogenesis in the ischemic limb of spontaneously hypertensive rats. Cardiovasc Res 2001; 52: 314–20.
Heeschen C, Weis M, Aicher A, Dimmeler S, Cooke JP . A novel angiogenic pathway mediated by non-neuronal nicotinic acetylcholine receptors. J Clin Invest 2002; 110: 527–36.
Duerschmied D, Ahrens I, Mauler M, Brandt C, Weidner S, Bode C, et al. Serotonin antagonism improves platelet inhibition in clopidogrel low-responders after coronary stent placement: an in vitro pilot study. PLoS One 2012; 7: e 32656.
Yabanoglu S, Akkiki M, Seguelas MH, Mialet-Perez J, Parini A, Pizzinat N . Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J Mol Cell Cardiol 2009; 46: 518–25.
Acknowledgements
This work was supported by grants from the National Natural Science Foundation of China (81102453, 81230083).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Yu, Jg., Zhang, Eh., Liu, Aj. et al. Ketanserin improves cardiac performance after myocardial infarction in spontaneously hypertensive rats partially through restoration of baroreflex function. Acta Pharmacol Sin 34, 1508–1514 (2013). https://doi.org/10.1038/aps.2013.147
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2013.147
